Gohealth Inc
NASDAQ:GOCO
Gohealth Inc
NASDAQ:GOCO
Price:
10.39 USD
2.77%
Market Closed
Updated:
May 7, 2024
Section:
Relative Value
The Relative Value of one
GOCO
stock under the Base Case scenario is
33.29
USD.
Compared to the current market price of 10.39 USD,
Gohealth Inc
is
Undervalued by 69%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GOCO
Relative Value
Base Case
33.29
USD
Undervaluation 69%
Valuation Multiples
Multiples Across Competitors
GOCO Competitors Multiples
Gohealth Inc Competitors
Gohealth Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Gohealth Inc
NASDAQ:GOCO
|
233.4m USD | 0.3 | -3.7 | 15.4 | -8.2 | |
| US |
|
Marsh & McLennan Companies Inc
NYSE:MMC
|
99.3B USD | 4.3 | 25.3 | 16.9 | 19.1 | |
| IE |
|
Aon PLC
NYSE:AON
|
56.7B USD | 4.2 | 21.9 | 13.8 | 14.7 | |
| US |
|
Arthur J Gallagher & Co
NYSE:AJG
|
52.8B USD | 5 | 48.7 | 21.6 | 29.6 | |
| US |
A
|
Arthur J. Gallagher & Co.
SWB:GAH
|
31.2B EUR | 3.2 | 30.8 | 14.6 | 20.1 | |
| UK |
W
|
Willis Towers Watson PLC
NASDAQ:WLTW
|
28.8B USD | 2.5 | 9.5 | 12.5 | 17.4 | |
| US |
|
Brown & Brown Inc
NYSE:BRO
|
24B USD | 5.5 | 26.2 | 17.6 | 20.4 | |
| US |
|
Ryan Specialty Group Holdings Inc
NYSE:RYAN
|
13.4B USD | 6.4 | 219.5 | 24.9 | 31.1 | |
| IN |
|
PB Fintech Ltd
NSE:POLICYBZR
|
572.6B INR | 17.8 | -22 323.7 | -201.5 | -156.3 | |
| AU |
|
Steadfast Group Ltd
ASX:SDF
|
6.3B AUD | 4.1 | 30.6 | 19.8 | 19.8 | |
| US |
|
Hagerty Inc
NYSE:HGTY
|
3B USD | 3 | 191 | 44.3 | 131.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
